Awards & Advancement

ERT named finalist for 2017 Scrip Award

Friday, September 22, 2017

ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, announced that ERT Trial Oversight—its centralized, cloud-based clinical trial management solution—has been named a finalist for the 2017 Scrip Best Sponsor-Focused Technological Development in Clinical Trials Award.

[Read More]

Envigo adds Craig Boyd and Lizanne Muller

Friday, September 22, 2017

Envigo has made two new appointments to its Executive Committee. The appointments of a Chief Commercial Officer and President of EMEA Operations have been made at a time of growth for Envigo during which the organization has been focused on improving the quality of the customer experience for its global customer base across the pharmaceutical, chemicals, and crop protection industries. Both of the positions report directly into Dr. Adrian Hardy, Chief Executive Officer of Envigo.

[Read More]

Cell Medica appoints Luis Borges as CSO to accelerate R&D for CAR and TCR Programs

Monday, September 18, 2017

Cell Medica, a provider of cell-based immunotherapies for the treatment of cancer, announced the appointment of Luis Borges, Ph.D., as Chief Scientific Officer. Luis will spearhead the Company’s global research group, including teams in London, Zurich and Houston. Luis brings extensive knowledge of cancer immunotherapy from twenty years of experience in the field, including senior positions at Five Prime Therapeutics and Amgen, where he played a senior role in the discovery and development of several blockbuster drugs and therapeutic candidate molecules.

[Read More]

Bracket adds Sam Whitaker as chief technology officer

Monday, September 18, 2017

Bracket, a clinical trial technology and specialty services provider, added Sam Whitaker as Chief Technology Officer (CTO) to its growing team. Whitaker joins Bracket’s leadership team bringing ten years of experience in clinical technology and global infrastructure innovation to the company.

[Read More]

Worldwide Clinical Trials receives finalist nomination for 2017 Scrip Awards

Monday, September 18, 2017

Worldwide Clinical Trials has been announced as a finalist for a second year in the 2017 “Best Contract Research Organization—Full Service Providers” category of the Scrip awards. The six shortlisted companies, chosen by a panel of 16 judges, were chosen for the innovation, dedication and hard work they have displayed in the pharmaceutical and biotech industries during the past year.

[Read More]

James Ostell named National Center for Biotechnology Information director

Thursday, September 14, 2017

National Library of Medicine (NLM) Director Patricia Flatley Brennan, R.N., Ph.D., has appointed James M. Ostell, Ph.D., as the director of the National Center for Biotechnology Information (NCBI), a division of NLM at the NIH. Dr. Ostell has been with NCBI since it was established by Congress in 1988, and has helped shape it into one of the most widely used biomedical resources in the world. 

[Read More]

Centauri Therapeutics receives Innovate UK Biomedical Catalyst Award

Tuesday, September 12, 2017

Centauri Therapeutics, a biotechnology company focused on the treatment of infectious diseases and cancer, has been awarded up to £945,000 under Innovate UK’s Biomedical Catalyst (BMC) program. Alongside backing from the company’s investors, this award from the U.K.’s innovation agency will co-fund research focused on antimicrobial resistance. The project aims to generate a clinical candidate drug against Gram-negative bacteria, which are a major cause of mortality in hospital-acquired pneumonias, using the company’s Alphamer technology.

[Read More]

Piramal Pharma Solutions names John Fowler COO

Tuesday, September 12, 2017

Piramal Pharma Solutions (PPS), part of Piramal Enterprises Limited, announce the appointment of John Fowler as its Chief Operating Officer. PPS is a leader in Integrated Contract Development and Manufacturing, with a global network of 12 development and manufacturing facilities across North America, Europe and Asia. PPS offers a comprehensive range of services including Drug Discovery Solutions, Process & Pharmaceutical Development services, Clinical Trial Supplies and Commercial supply of APIs and Finished dosage forms. As Chief Operating Officer, John will be responsible for Global Operations and Research & Development (R&D), and will play a lead role in ensuring that our customers consistently experience differentiated and excellent levels of service.

[Read More]